ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.

Anfal Alsadhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.